Targeting the Brain in Type 2 Diabetes: Therapeutics to Induce Remission – Dr Jarrad Scarlett, University of Washington

Mar 6, 2020 | health and medicine

Original Article Reference

https://doi.org/10.33548/SCIENTIA463

About this episode

Type 2 diabetes (T2D) is among the most impactful and costly biomedical challenges confronting society. Current treatment regimens for T2D rely upon daily drug dosing and frequent glucose monitoring to normalise blood glucose levels. However, these medications can only delay disease progression and frequently have undesired side effects including hypoglycaemia and weight gain. Growing evidence supports a key role for the brain in glucose homeostasis and diabetes pathogenesis. Dr Jarrad Scarlett and his research team at the University of Washington and Seattle Children’s Hospital are working on the development of novel pharmaceuticals to target the brain to induce sustained remission of T2D.

 

 

 

 

This work is licensed under a Creative Commons Attribution 4.0 International LicenseCreative Commons License

What does this mean?

Share: You can copy and redistribute the material in any medium or format

Adapt: You can change, and build upon the material for any purpose, even commercially.

Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.

Related episodes

Troy Norris | The Wellbeing Balance Model: A Personalized Approach to Design Effective Wellbeing Interventions

Troy Norris | The Wellbeing Balance Model: A Personalized Approach to Design Effective Wellbeing Interventions

Research from Troy Norris at the WellBalance Institute for Positive Wellbeing reveals how a novel approach to measuring wellbeing can lead to more effective personalized interventions. The Wellbeing Balance and Lived Experiences (or WellBalance) Model and Assessment extends traditional wellbeing measures by evaluating both positive experiences and the feelings they generate, enabling tailored approaches to enhance individual flourishing based on specific life circumstances.

Dr. Alex Chaparro | Deciding when and how checklists should be used in medicine

Dr. Alex Chaparro | Deciding when and how checklists should be used in medicine

While checklists are often a vital tool for medical procedures, there has so far been little guidance on how they should be designed and applied in real medical scenarios. Now, a team including Dr. Alex Chaparro, a researcher at Embry-Riddle Aeronautical University, has developed an algorithm which can help medical experts to decide when a checklist is the best-suited tool for the task at hand; and if so, which type of checklist should be applied, based on the user’s technical experience. The approach could ultimately help complex, potentially urgent medical procedures to become safer and more efficient.

Professor Mamta Jain | Improving Hepatitis C Screening and Care: Approaches for Reaching Underserved Populations

Professor Mamta Jain | Improving Hepatitis C Screening and Care: Approaches for Reaching Underserved Populations

Research from Professor Mamta Jain at UT Southwestern Medical Center and her colleagues reveals how electronic alerts, patient navigation, and mailed outreach can significantly increase hepatitis C screening and treatment in traditionally difficult-to-reach populations. Their work demonstrates that while electronic reminders are effective, combining multiple approaches with adequate clinical staffing and resources leads to the greatest improvements in patient care across all stages of the hepatitis C care continuum.

Dr. Hanieh Razzaghi | Behind the Screens: Improving Health Outcomes with Better Data

Dr. Hanieh Razzaghi | Behind the Screens: Improving Health Outcomes with Better Data

We can imagine our health as a jigsaw, with each individual piece representing a different aspect of our medical history. These pieces might include blood test results, X-ray images or the notes taken by a doctor as we describe our symptoms. These jigsaw pieces are ultimately recorded and stored in electronic health records (or EHRs). EHRs are a valuable resource, providing an overview of someone’s health and they could have the potential to allow clinicians and researchers to unlock new medical insights. However, there’s a fly in the ointment – not all the pieces in such records always fit together correctly, and they may not completely capture the required information. Some clinical event documentation may not be complete, others do not align with related pieces, and some events are even missing entirely. This data quality problem was tackled by Dr. Hanieh Razzaghi of the Children’s Hospital of Philadelphia, and her colleagues, in their innovative work on the PRESERVE study, a research project exploring chronic kidney disease in children (the PRESERVE study itself was led by Drs. Michelle Denburg and Christopher Forrest). Using EHRs from 15 different hospitals across the United States, the team aimed to understand how various treatments could potentially slow down chronic kidney disease progression. However, initially, they had to make sure that the data they were relying on were accurate, reliable, and suitable for the required complex analyses.

Increase the impact of your research

• Good science communication helps people make informed decisions and motivates them to take appropriate and affirmative action.
• Good science communication encourages everyday people to be scientifically literate so that they can analyse the integrity and legitimacy of information.
• Good science communication encourages people into STEM-related fields of study and employment.
• Good public science communication fosters a community around research that includes both members of the public, policymakers and scientists.
• In a recent survey, 75% of people suggested they would prefer to listen to an interesting story than read it.

Step 1 Upload your science paper

Step 2 SciPod script written

Step 3 Voice audio recorded

Step 4 SciPod published